Skip to content

FreeStyle Libre 3 AppRecalls & reported problems across all models

Abbott Diabetes Care Inc · 2 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
64
Deaths reported
0
Injuries reported
64
Recalls
1

We found 2 models of FreeStyle Libre 3 App by Abbott Diabetes Care Inc in the FDA's device registry (GUDID). Together they are named in 64 adverse event reports in the FDA's MAUDE database, received between Sep 6, 2023 and Mar 9, 2026 — classified as 64 injuries.

The most frequently reported specific device problem is “Application Program Problem” (55 reports).

1 FDA recall record name at least one of these models by its device identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 5 reportsMar 2024: 4 reportsApr 2024: 2 reportsMay 2024: 3 reportsJun 2024: 2 reportsJul 2024: 2 reportsAug 2024: 1 reportsSep 2024: 5 reportsOct 2024: 7 reportsNov 2024: 3 reportsDec 2024: 1 reportsJan 2025: 3 reportsFeb 2025: 2 reportsMar 2025: 1 reportsApr 2025: 1 reportsMay 2025: 2 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 3 reportsSep 2025: 1 reportsOct 2025: 1 reportsNov 2025: 2 reportsDec 2025: 3 reportsJan 2026: 1 reportsFeb 2026: 2 reportsMar 2026: 2 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520267
Last 36 months. The most recent month may be incomplete.

FreeStyle Libre 3 App recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Feb 9, 2023Completed

    If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.

    Z-0734-2024 · Root cause: Software design · Recall details · FDA record ↗

Most reported FreeStyle Libre 3 App problems

Device problems

  • Application Program Problem55
  • Device Alarm System32
  • Unable to Obtain Readings11
  • Device Displays Incorrect Message3
  • Communication or Transmission Problem1
  • Compatibility Problem1
  • Computer Operating System Problem1
  • Incorrect, Inadequate or Imprecise Result or Readings1

Patient problems

  • Hypoglycemia38
  • Loss of consciousness25
  • No Clinical Signs, Symptoms or Conditions13
  • Diaphoresis8
  • Dizziness8
  • Convulsion/Seizure7
  • Confusion/ Disorientation3
  • Hyperglycemia3

FreeStyle Libre 3 App models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent FreeStyle Libre 3 App adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Abbott Diabetes Care Inc products

All Abbott Diabetes Care Inc devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page